Journal of Pharmacology and Toxicology1816-496x2152-100xAcademic Journals Inc.10.3923/jpt.2017.170.179MarabiniLaura NegliaLaura MonguzziErika GalliCorrado L. MarinovichMarina 42017124Background and Objective: Myristicin belongs to a class of potentially toxic chemicals (alkoxy substituted allylbenzenes) and despite the structural analogy with safrole, data on this compound are very controversial and unclear. In this study assessed the cytotoxic and genotoxic potential of myristicin and 1-hydroxy-myristicin after 24 h of exposure in HepG2 cells. Methodology: The compounds were tested up to 600 μM concentration, for 24 h. The genotoxicity was assessed with alkaline and neutral comet assay and micronucleus assay. The data were analysed by one-way ANOVA. Results: It is to be emphasized that only the synthetic Phase 1 metabolite (1-hydroxymyristicin) showed a genotoxic effect starting from the concentration of 150 μM both in comet and micronucleus tests. However, it is important to point out that the same concentration cause a statistically significant (p<0.001) apoptotic process. Conclusion: The consumption of a traditional diet determines very low levels of exposure to the parent myristicin. This fact implies as the primary metabolic pathway the O-demethylation (5-allyl-2,3-dihidroxyanisole) and not to Phase I metabolism, which leads to the conclusion that this substance could not present a significant risk to humans.]]>Hallstrom, H. and A. Thuvander,19975186192Martins, C., C. Doran, A. Laires, J. Rueff and A.S. Rodrigues,201149385392Van den Berg, S.J.P.L., A. Punt, A.E.M.F. Soffers, J. Vervoort, S. Ngeleja, B. Spenkelink and I.M.C.M. Rietjens,20122523522367SCF.,20012001SCF.,20012001SCF.,20012001Rietjens, I.M.C.M., S.M. Cohen, S. Fukusima,, N.J. Gooderham and S. Hecht et al.,20142710921103Van den Berg, S.J.P.L., P. Restani, M.G. Boersma, L. Delmulle and I.M.C.M. Rietjens,201129891010Phillips, D.H., M.V. Reddy and K. Randerath,1984516231628Randerath, K., R.E. Haglund, D.H. Phillips and M.V. Reddy,1984516131622Marcus, C. and E.P. Lichtenstein,198230563568Hasheminejad, G. and J. Caldwell,199432223231Lee, B.K., J.H. Kim, JW. Jung, J.W. Choi and E.S. Han et al.,20051574956Martins, C., C. Doran, I.C. Silva., C. Miranda, J. Rueff and A.S. Rodrigues,201421819Al-Malahmeh A.J., A. Al-Ajlouni, S. Wesseling , A.E.M.F. Soffers and A. Al-Subeih et al.,201791713734Zangouras, A., J. Caldwell, A.J. Huttand and R.L. Smith,19813013831386Zhou, G.D., B. Moorthy, J. Bi, K.C. Donnelly and K. Randerath,200748715721Schiller, C.D., A. Kain, K. Mynettand and A. Gescher,19926575578Rodrigues, R.M., M. Bouhifd, G. Bories, M.G. Sacco and L. Gribaldo et al.,2013in vitro basal cytotoxicity test system based on metabolically-competent cells.]]>27760767Singh, N.P., M.T. McCoy, R.R. Tice and E.L. Schneider,1988175184191Bryce, S.M., J.C. Bemis, S.L. Avlasevich and S.D. Dertinger,2007In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.]]>6307891Boberg, E.W., E.C. Miller, J.A. Miller, A. Poland and A. Liem,19834351635173Drinkwater, N.R., E.C. Miller, J.A. Miller and H.C. Pitot,19765713231331Swanson, A.B., E.C. Miller and J.A. Miller,1981673504516Miller, J.A., E.C. Millerand and D.H. Phillips,19821982pp: 83-96pp: 83-96Miller, E.C., A.B. Swanson, D.H. Phillips, L. Fletcher, A. Liem and J.A. Miller,19834311241134Gardner, I., P. Bergin and P. Stening,19951995Gardner, I., P. Bergin, P. Stening, J.G. Kenna and J. Caldwell,19969713721Daimon, H., S. Sawada, S. Asakura and F. Sagami,1998In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole.]]>19141146Knasmuller, S., W. Parzefall, R. Sanyal, S. Ecker and C. Schwab et al.,1998402185202Smith, R.L., T.B. Adams, J. Doull, V.J. Feron and J.I. Goodman et al.,200240851870Chan, V.S. and J. Caldwell,199230831836Rietjens, I.M.C.M., M.G. Boersma, H. van der Woude, S.M.F. Jeurissen, M.E. Schutte and G.M. Alink,2005574124138Rietjens, I.M.C.M., W. Slob, C. Galli and V. Silano,2008180131136